{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T20:41:17Z","timestamp":1770496877814,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,10,30]],"date-time":"2012-10-30T00:00:00Z","timestamp":1351555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,10,30]],"date-time":"2012-10-30T00:00:00Z","timestamp":1351555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s10067-012-2105-2","type":"journal-article","created":{"date-parts":[[2012,10,29]],"date-time":"2012-10-29T19:08:13Z","timestamp":1351537693000},"page":"141-147","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence"],"prefix":"10.1007","volume":"32","author":[{"given":"Hubert","family":"de Boysson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9rome","family":"F\u00e9vrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Am\u00e9lie","family":"Nicolle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Auzary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lo\u00efk","family":"Geffray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,30]]},"reference":[{"key":"2105_CR1","first-page":"424","volume":"19","author":"M Yamaguchi","year":"1992","unstructured":"Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H (1992) Preliminary criteria for classification of adult Still's disease. J Rheumatol 19:424\u2013430","journal-title":"J Rheumatol"},{"issue":"5","key":"2105_CR2","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.berh.2008.08.006","volume":"22","author":"B Fautrel","year":"2008","unstructured":"Fautrel B (2008) Adult-onset Still disease. Best Pract Res Clin Rheumatol 22(5):773\u2013792. doi:10.1016\/j.berh.2008.08.006","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"5","key":"2105_CR3","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1093\/rheumatology\/kep441","volume":"49","author":"ML Cunha","year":"2010","unstructured":"Cunha ML, Wagner J, Osawa A, Scheinberg M (2010) The effect of tocilizumab on the uptake of 18FDG-PET imaging in patients with adult-onset Still's disease. Rheumatology (Oxford) 49(5):1014\u20131016","journal-title":"Rheumatology (Oxford)"},{"key":"2105_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/ard.2008.088179","volume":"68","author":"M De Bandt","year":"2009","unstructured":"De Bandt M, Saint-Marcoux B (2009) Tocilizumab for multi-refractory adult-onset Still's disease. Ann Rheum Dis 68:153\u2013154","journal-title":"Ann Rheum Dis"},{"key":"2105_CR5","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1002\/art.10620","volume":"46","author":"M Iwamoto","year":"2002","unstructured":"Iwamoto M, Nara H, Hirata D, Minota S, Nishimoto N, Yoshizaki K (2002) Humanized monoclonal anti-interleukin-6 receptor antibody for treatment of intractable adult-onset Still's disease. Arthritis Rheum 46:3388\u20133389","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2105_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10165-010-0365-8","volume":"21","author":"D Kishida","year":"2011","unstructured":"Kishida D, Okuda Y, Onishi M, Takebayashi M, Matoba K, Jouyama K, Yamada A, Sawada N, Mokuda S, Takasugi K (2011) Successful tocilizumab treatment in a patient with adult-onset Still's disease complicated by chronic active hepatitis B and amyloid A amyloidosis. Mod Rheumatol Jpn Rheum Assoc 21(2):215\u2013218. doi:10.1007\/s10165-010-0365-8","journal-title":"Mod Rheumatol Jpn Rheum Assoc"},{"issue":"1","key":"2105_CR7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s10165-010-0348-9","volume":"21","author":"M Kobayashi","year":"2011","unstructured":"Kobayashi M, Takahashi Y, Yamashita H, Kaneko H, Mimori A (2011) Benefit and a possible risk of tocilizumab therapy for adult-onset Still's disease accompanied by macrophage-activation syndrome. Mod Rheumatol Jpn Rheum Assoc 21(1):92\u201396. doi:10.1007\/s10165-010-0348-9","journal-title":"Mod Rheumatol Jpn Rheum Assoc"},{"issue":"1","key":"2105_CR8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.medcli.2011.04.002","volume":"138","author":"R Lopez Buitrago","year":"2012","unstructured":"Lopez Buitrago R, Estrada Dorronsoro S, Cervera Segura R, Espinosa Garriga G (2012) Tocilizumab effectiveness in adult Still's disease. Med Clin (Barc) 138(1):42\u201343","journal-title":"Med Clin (Barc)"},{"issue":"4","key":"2105_CR9","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s10067-009-1097-z","volume":"28","author":"K Matsumoto","year":"2009","unstructured":"Matsumoto K, Nagashima T, Takatori S, Kawahara Y, Yagi M, Iwamoto M, Okazaki H, Minota S (2009) Glucocorticoid and cyclosporine refractory adult onset Still's disease successfully treated with tocilizumab. Clin Rheumatol 28(4):485\u2013487. doi:10.1007\/s10067-009-1097-z","journal-title":"Clin Rheumatol"},{"key":"2105_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10165-008-0116-2","volume":"19","author":"H Nakahara","year":"2009","unstructured":"Nakahara H, Mima T, Yoshio-Hoshino N, Matsushita M, Hashimoto J, Nishimoto N (2009) A case report of a patient with refractory adult-onset Still's disease who was successfully treated with tocilizumab over 6\u00a0years. Mod Rheumatol Jpn Rheum Assoc 19:69\u201372","journal-title":"Mod Rheumatol Jpn Rheum Assoc"},{"key":"2105_CR11","doi-asserted-by":"publisher","unstructured":"Naniwa T, Ito R, Watanabe M, Hayami Y, Maeda S, Sasaki K, Iwagaitsu S (2010) Case report: successful use of short-term add-on tocilizumab for multirefractory systemic flare of adult-onset Still's disease. Clin Rheumatol. doi:10.1007\/s10067-010-1562-8","DOI":"10.1007\/s10067-010-1562-8"},{"key":"2105_CR12","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1007\/s10067-010-1553-9","volume":"29","author":"K Perdan-Pirkmajer","year":"2010","unstructured":"Perdan-Pirkmajer K, Praprotnik S, Tomsic M (2010) A case of refractory adult-onset Still's disease successfully controlled with tocilizumab and a review of the literature. Clin Rheumatol 29:1465\u20131467","journal-title":"Clin Rheumatol"},{"issue":"1","key":"2105_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/acr.20319","volume":"63","author":"X Puechal","year":"2011","unstructured":"Puechal X, DeBandt M, Berthelot JM, Breban M, Dubost JJ, Fain O, Kahn JE, Lequen L, Longy-Boursier M, Perdriger A, Schaeverbeke T, Toussirot E, Sibilia J (2011) Tocilizumab in refractory adult Still's disease. Arthritis Care Res (Hoboken) 63(1):155\u2013159. doi:10.1002\/acr.20319","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"2105_CR14","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1136\/ard.2010.129403","volume":"70","author":"J Rech","year":"2011","unstructured":"Rech J, Ronneberger M, Englbrecht M, Finzel S, Katzenbeisser J, Manger K, Manger B, Schett G (2011) Successful treatment of adult-onset Still's disease refractory to TNF and IL-1 blockade by IL-6 receptor blockade. Ann Rheum Dis 70(2):390\u2013392. doi:10.1136\/ard.2010.129403","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"2105_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.pharma.2012.03.001","volume":"70","author":"A Rkiouak","year":"2012","unstructured":"Rkiouak A, Ennibi K, Zinebi A, Akhouad Y, Reggad A, Rabhi M, Chaari J (2012) Adult refractory Still disease with atypical articular manifestations: efficacity of interleukin-6 antagonists (tocilizumab). Ann Pharm Fr 70(3):163\u2013168. doi:10.1016\/j.pharma.2012.03.001","journal-title":"Ann Pharm Fr"},{"issue":"4","key":"2105_CR16","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.semarthrit.2010.05.003","volume":"40","author":"GR Sabnis","year":"2011","unstructured":"Sabnis GR, Gokhale YA, Kulkarni UP (2011) Tocilizumab in refractory adult-onset Still's disease with aseptic meningitis\u2013efficacy of interleukin-6 blockade and review of the literature. Semin Arthritis Rheum 40(4):365\u2013368. doi:10.1016\/j.semarthrit.2010.05.003","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"2105_CR17","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10067-011-1917-9","volume":"31","author":"R Sakai","year":"2012","unstructured":"Sakai R, Nagasawa H, Nishi E, Okuyama A, Takei H, Kurasawa T, Kondo T, Nishimura K, Shirai Y, Ito T, Kameda H, Takeuchi T, Amano K (2012) Successful treatment of adult-onset Still's disease with tocilizumab monotherapy: two case reports and literature review. Clin Rheumatol 31(3):569\u2013574. doi:10.1007\/s10067-011-1917-9","journal-title":"Clin Rheumatol"},{"issue":"7\u20138","key":"2105_CR18","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.lpm.2011.03.012","volume":"40","author":"Y Sekkach","year":"2011","unstructured":"Sekkach Y, Elqatni M, Khattabi AE, Fatihi J, Hammi S, Badaoui M, Elomri N, Mekouar F, Amezyane T, Abouzahir A, Ghafir D (2011) Antagonists of interleukin-6 (tocilizumab), in adult refractory still disease. Press Med 40(7\u20138):333\u2013337. doi:10.1016\/j.lpm.2011.03.012","journal-title":"Press Med"},{"issue":"10","key":"2105_CR19","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s10067-010-1418-2","volume":"29","author":"K Sumida","year":"2010","unstructured":"Sumida K, Ubara Y, Hoshino J, Suwabe T, Hiramatsu R, Hasegawa E, Hayami N, Yamanouchi M, Sawa N, Takemoto F, Takaichi K (2010) Etanercept-refractory adult-onset Still's disease with thrombotic thrombocytopenic purpura successfully treated with tocilizumab. Clin Rheumatol 29(10):1191\u20131194. doi:10.1007\/s10067-010-1418-2","journal-title":"Clin Rheumatol"},{"issue":"12","key":"2105_CR20","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1007\/s00296-010-1631-y","volume":"31","author":"R Thonhofer","year":"2011","unstructured":"Thonhofer R, Hiller M, Just H, Trummer M, Siegel C, Dejaco C (2011) Treatment of refractory adult-onset Still's disease with tocilizumab: report of two cases and review of the literature. Rheumatol Int 31(12):1653\u20131656. doi:10.1007\/s00296-010-1631-y","journal-title":"Rheumatol Int"},{"issue":"16","key":"2105_CR21","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.2169\/internalmedicine.50.4771","volume":"50","author":"Y Yoshida","year":"2011","unstructured":"Yoshida Y, Sakamoto M, Yokota K, Sato K, Mimura T (2011) Tocilizumab improved both clinical and laboratory manifestations except for interleukin-18 in a case of multiple drug-resistant adult-onset Still's disease. Intern Med 50(16):1757\u20131760","journal-title":"Intern Med"},{"issue":"1","key":"2105_CR22","first-page":"141","volume":"28","author":"M Yoshimura","year":"2010","unstructured":"Yoshimura M, Makiyama J, Koga T, Miyashita T, Izumi Y, Torigoshi T, Motokawa S, Eguchi K, Migita K (2010) Successful treatment with tocilizumab in a patient with refractory adult-onset Still's disease (AOSD). Clin Exp Rheumatol 28(1):141\u2013142","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"2105_CR23","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1002\/art.21061","volume":"52","author":"AA Fitzgerald","year":"2005","unstructured":"Fitzgerald AA, Leclercq SA, Yan A, Homik JE, Dinarello CA (2005) Rapid responses to anakinra in patients with refractory adult-onset Still's disease. Arthritis Rheum 52(6):1794\u20131803. doi:10.1002\/art.21061","journal-title":"Arthritis Rheum"},{"issue":"11","key":"2105_CR24","first-page":"2189","volume":"31","author":"DY Chen","year":"2004","unstructured":"Chen DY, Lan JL, Lin FJ, Hsieh TY (2004) Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease. J Rheumatol 31(11):2189\u20132198","journal-title":"J Rheumatol"},{"issue":"6","key":"2105_CR25","first-page":"653","volume":"14","author":"MA Scheinberg","year":"1996","unstructured":"Scheinberg MA, Chapira E, Fernandes ML, Hubscher O (1996) Interleukin 6: a possible marker of disease activity in adult onset Still's disease. Clin Exp Rheumatol 14(6):653\u2013655","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"2105_CR26","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.1182\/blood-2008-05-155846","volume":"112","author":"N Nishimoto","year":"2008","unstructured":"Nishimoto N, Terao K, Mima T, Nakahara H, Takagi N, Kakehi T (2008) Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease. Blood 112(10):3959\u20133964. doi:10.1182\/blood-2008-05-155846","journal-title":"Blood"},{"issue":"9617","key":"2105_CR27","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/S0140-6736(08)60454-7","volume":"371","author":"S Yokota","year":"2008","unstructured":"Yokota S, Imagawa T, Mori M, Miyamae T, Aihara Y, Takei S, Iwata N, Umebayashi H, Murata T, Miyoshi M, Tomiita M, Nishimoto N, Kishimoto T (2008) Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial. Lancet 371(9617):998\u20131006. doi:10.1016\/S0140-6736(08)60454-7","journal-title":"Lancet"},{"issue":"9","key":"2105_CR28","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1136\/ard.2006.068064","volume":"66","author":"N Nishimoto","year":"2007","unstructured":"Nishimoto N, Hashimoto J, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Murata N, van der Heijde D, Kishimoto T (2007) Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab. Ann Rheum Dis 66(9):1162\u20131167. doi:10.1136\/ard.2006.068064","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"2105_CR29","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1136\/ard.2005.046904","volume":"65","author":"JB Arlet","year":"2006","unstructured":"Arlet JB, Le TH, Marinho A, Amoura Z, Wechsler B, Papo T, Piette JC (2006) Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literature. Ann Rheum Dis 65(12):1596\u20131601. doi:10.1136\/ard.2005.046904","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"2105_CR30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.cyto.2012.02.006","volume":"58","author":"M Shimizu","year":"2012","unstructured":"Shimizu M, Nakagishi Y, Kasai K, Yamasaki Y, Miyoshi M, Takei S, Yachie A (2012) Tocilizumab masks the clinical symptoms of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: the diagnostic significance of interleukin-18 and interleukin-6. Cytokine 58(2):287\u2013294. doi:10.1016\/j.cyto.2012.02.006","journal-title":"Cytokine"},{"issue":"1","key":"2105_CR31","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.clim.2004.03.023","volume":"112","author":"O Saiki","year":"2004","unstructured":"Saiki O, Uda H, Nishimoto N, Miwa T, Mima T, Ogawara T, Azuma N, Katada Y, Sawaki J, Tsutsui H, Matsui K, Maeda A, Nakanishi K (2004) Adult Still's disease reflects a Th2 rather than a Th1 cytokine profile. Clin Immunol 112(1):120\u2013125. doi:10.1016\/j.clim.2004.03.023","journal-title":"Clin Immunol"},{"issue":"3","key":"2105_CR32","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/BOR.0b013e3283295fec","volume":"21","author":"T Mima","year":"2009","unstructured":"Mima T, Nishimoto N (2009) Clinical value of blocking IL-6 receptor. Curr Opin Rheumatol 21(3):224\u2013230. doi:10.1097\/BOR.0b013e3283295fec","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"2105_CR33","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/RHU.0b013e31822c53ad","volume":"17","author":"RA Ostrowski","year":"2011","unstructured":"Ostrowski RA, Tehrani R, Kadanoff R (2011) Refractory adult-onset still disease successfully treated with abatacept. J Clin Rheumatol: Pract Rep Rheum Musculoskelet Dis 17(6):315\u2013317. doi:10.1097\/RHU.0b013e31822c53ad","journal-title":"J Clin Rheumatol: Pract Rep Rheum Musculoskelet Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-012-2105-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-012-2105-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-012-2105-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-012-2105-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T16:17:09Z","timestamp":1659111429000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-012-2105-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,30]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["2105"],"URL":"https:\/\/doi.org\/10.1007\/s10067-012-2105-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,30]]},"assertion":[{"value":"19 September 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}